The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein

REFERENCES

• Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076–9.
   Google Scholar
• Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54–9.
   Google Scholar
• Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J Med 1994; 87: 403–6.
   Google Scholar
• Junker R, Heinrich J, Schulte H, van de Loo J, Assman G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 1539–44.
   PubMedGoogle Scholar
• Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia irrespective of die-tary fat composition. Atherosclerosis 1991; 86: 163 —71.
   PubMedGoogle Scholar
• Marckmann P, Sandstrom B, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Athero-sclerosis 1993; 101: 225–34.
   Google Scholar
• Salomaa V, Rasi V, Pekkanen, Jauhianen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C. The effect of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and haemostatic activity. Atherosclerosis 1993; 103: 1–11.
   Google Scholar
• Bladbjerg E-M, Marckmann P, Sandstrom B, Jespersen J. Non-fasting factor VII coagulant activity ( FVII : C) increased by high-fat diet. Thromb Haemost 1994; 71: 755–8.
   Google Scholar
• Mitropoulos KA, Miller GJ, Martin JC, Reeves BE, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214–22.
   Google Scholar
• Silveira A, Green F, Karpe F, Blombäck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994; 72: 734–9.
   Google Scholar
• Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagula-tion factor VII during alimentary lipemia. Ar-terioscler Thromb 1994; 14: 60–9.
   Google Scholar
• Kapur R, Hoffman CJ, Bhushan V, Hultin MB. Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol 1996; 16: 1327–32.
   PubMed Web of Science ®Google Scholar
• Miller GJ, Martin JC, Mitropoulos KA, Esnouf MP, Cooper JA, Morrissey JH, Howarth DJ, Tuddenham EGD. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood 1996; 87: 4187–96.
   PubMed Web of Science ®Google Scholar
• Sanders TAB, Miller GJ, de Grassi T, Yahia N. Postprandial activation of coagulant factor VII by long chain dietary fatty acids. Thromb Haemost 1996; 76: 369–71.
   PubMedGoogle Scholar
• Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 1996; 16: 1333–9.
   Google Scholar
• Larsen LF, Bladbjerg E-M, Jespersen J, Marckmann P. Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler Thromb Vasc Biol 1997; 17: 2904–9.
   Google Scholar
• Marckmann P, Bladbjerg E-M, Jespersen J. Die-tary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 3384–91.
   PubMed Web of Science ®Google Scholar
• Roche HM, Gibney MJ. Postprandial coagulation factor VII activity: the effect of monounsaturated fatty acids. Br J Nutr 1997; 77: 537–49.
   PubMedGoogle Scholar
• Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems. Roles of activated factor 1X, kallikrein and activated factor XII. J Clin Invest 1979; 64: 1056–65.
   Google Scholar
• Mitropoulos KA, Martin JC, Reeves BEA, Esnouf MP. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles. Blood 1989; 73: 1525–33.
   PubMedGoogle Scholar
• Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein deficiency. Athero-sclerosis 1992; 95: 119–25.
   PubMedGoogle Scholar
• Nemerson Y, Repke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351–8.
   PubMed Web of Science ®Google Scholar
• Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor depen- dent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819–24.
   PubMedGoogle Scholar
• Laake K, Osterud B. Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of human intrinsic blood coagulation system. Thromb Res 1974; 5: 759— 72.
   PubMedGoogle Scholar
• Stormorken H, Abildgaard CF. The fletcher factor-prekallikrein deficiency: a diagnostic test which identifies heterozygotes. Thromb Res 1974; 5: 375–8.
   PubMedGoogle Scholar
• Gjonnxss H. Cold promoted activation of factor VII. III. Relation to the kallikrein system. Thromb Diath Haemorrh 1972; 28: 182–93.
   PubMedGoogle Scholar
• Wildgoose P, Kisiel W. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood 1989; 73: 1888–95.
   PubMedGoogle Scholar
• Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731 — 6.
   Google Scholar
• Ceriello A, Giuliano D, Quatraro A, Russo PD, Torella R. Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetolo-gia 1988; 31: 889–91.
   Google Scholar
• Almdahl SM, Nilsen DWT, Osterud B, Sorlie DG, Vaage J. Thromboplastin activities and monocytes in the coronary circulation of reperfused human myocardium. Scand J Thorac Cardiovasc Surg 1993; 27: 81–6.
   PubMed Web of Science ®Google Scholar
• Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 1967; 21: 53.
   Google Scholar
• Ford RP, Esnouf MP, Byrgess Al, Sarphie A. An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hage-man factor) in human plasma. J Immunoassay 1996; 17: 119–31.
   PubMedGoogle Scholar
• Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest 1972; 29: 21.
   Web of Science ®Google Scholar
• Gallimore MJ, Friberger P. Simple chromogenic peptide substrate assays for determining prekal-likrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Thromb Res 1982; 25: 293–8.
   PubMed Web of Science ®Google Scholar
• Ostergaard PB, Beck TC, Orsted H, Svendsen A, Nordfang 0, Sandset PM, Hansen J-B. An enzyme-linked immunosorbent assay for tissue factor pathway inhibitor. Thromb Res 1997; 87: 447— 59.
   Google Scholar
• Hansen J-B, Huseby KR, Huseby N-E, Sandset PM, Hanssen T-A, Nordoy A. Effects of choles-terol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipo-proteinemia. Arterioscler Thromb Vasc Biol 1995; 15: 879–85.
   Google Scholar
• Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coag Fibrinol 1991; 2: 713–21.
   PubMedGoogle Scholar
• Hansen J-B, Huseby KR, Huseby N-E, Ezban M, Nordoy A. Tissue factor pathway inhibitor in complex with low density lipoproteins isolated from human plasma does not possess anticoagu-lant function in tissue factor-induced coagulation in vitro. Thromb Res 1997; 85: 413–25.
   Google Scholar
• Osterud B, Bögwald J, Lindahl U, Seljelid R. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett 1981; 127: 154–6.
   PubMed Web of Science ®Google Scholar
• Matthews JNS, Altman DG, Campbell MJ, Royson P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230–5.
   PubMed Web of Science ®Google Scholar
• Osterud B, Laake K, Prydz H. The activation of human factor IX. Thromb Diath Haemorrh 1975; 33: 553–63.
   PubMedGoogle Scholar
• Mitropoulos KA, Reeves BEA, O'Brien DP, Cooper JA, Martin JC. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface. Blood Coag Fibrinol 1993; 4: 223–34.
   Google Scholar
• Walker ID. Blood collection and sample prepara-tion: pre-analytical variation. In: Jespersen J, Bertina RM, Haverkate F, editors. Laboratory techniques in thrombosis. A manual. 2nd revised edition of ECAT Assay procedures. Dordrecht: Kluwer Academic Publishers; 1999. pp. 21–8
   Google Scholar
• Lattanzio A, Montemurro P, Pannarale 0, Altomare DF, Palasciano N, de Rinaldis P, Semeraro N. Increased production of procoagu-lant activity (tissue factor) by human peripheral blood monocytes after intralipid infusions. Clin Nutr 1984; 3: 177–81.
   Google Scholar
• Warr TA, Warn-Cramer BJ, Rao LVM, Rapaport SI. Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiological variables. Blood 1989; 74: 201–6.
   Google Scholar
• Freese R, Mutanen M. Postprandial changes in platelet function and coagulation factors after high-fat meals with different fatty acid composi-tions. Eur J Clin Nutr 1995; 49: 658–64.
   PubMedGoogle Scholar
• van der Poll T, Coyle SM, Levi M, Boermeester MA, Braxton CC, Jansen PM, Hack CE, Lowry SF. Fat emulsion infusion potentiates coagulation activation during human endotoxemia. Thromb Haemost 1996; 75: 83–6.
   PubMed Web of Science ®Google Scholar
• Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839–43.
   PubMed Web of Science ®Google Scholar
• Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997; 349: 769–71.
   PubMed Web of Science ®Google Scholar
• Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, Topol EJ. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 1995; 92: 3041–50.
   Google Scholar
• Speidel CM, Thornton JD, Meng YY, Eisenberg PR, Edgington TS, Abendschein DR. Procoagu-lant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Coronary Artery Dis 1996; 7: 57–62.
   PubMedGoogle Scholar
• Kalafatis M, Swords NA, Rand MD, Mann KG. Membrane-dependent reactions in blood coagula-tion: role of the vitamin K-dependent complexes. Biochim Biophys Acta 1994; 1227: 113–29.
   PubMed Web of Science ®Google Scholar
• Eisenberg PR, Ghigliotti G. Platelet-dependent and procoagulant mechanisms in arterial throm-bosis. Int J Cardiol 1999; 68: S3–10.
   Google Scholar